These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17590270)

  • 21. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.
    Wan YJ; Yang Y; Leng QL; Lan B; Jia HY; Liu YH; Zhang CZ; Cao Y
    Cell Signal; 2014 Oct; 26(10):2202-9. PubMed ID: 24880064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vav1 regulates MHCII expression in murine resting and activated B cells.
    Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
    Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1
    De Vita S; Li Y; Harris CE; McGuinness MK; Ma C; Williams DA
    Stem Cells; 2018 Mar; 36(3):446-457. PubMed ID: 29235178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vav1 in differentiation of tumoral promyelocytes.
    Bertagnolo V; Brugnoli F; Grassilli S; Nika E; Capitani S
    Cell Signal; 2012 Mar; 24(3):612-20. PubMed ID: 22133616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA; Zheng Y; Cancelas JA
    Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis.
    Bertagnolo V; Grassilli S; Bavelloni A; Brugnoli F; Piazzi M; Candiano G; Petretto A; Benedusi M; Capitani S
    J Proteome Res; 2008 Sep; 7(9):3729-36. PubMed ID: 18642942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
    Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
    Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
    Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
    Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
    Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
    Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vav1 Promotes B-Cell Lymphoma Development.
    Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ha-ras in normal and tumoral tissues: structure, function and regulation.
    Solanas M; Escrich E
    Rev Esp Fisiol; 1996 Sep; 52(3):173-92. PubMed ID: 8974153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular oncogenes and cancer.
    Cooper GM
    Clin Physiol Biochem; 1987; 5(3-4):122-9. PubMed ID: 3621795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav1 as a central regulator of invadopodia assembly.
    Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
    Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output.
    Rodríguez-Fdez S; Citterio C; Lorenzo-Martín LF; Baltanás-Copado J; Llorente-González C; Corbalán-García S; Vicente-Manzanares M; Bustelo XR
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes.
    Hjorthaug HS; Aasheim HC
    Eur J Immunol; 2007 Aug; 37(8):2326-36. PubMed ID: 17634955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.